DOCU insider filing shows Rule 10b5-1 sale, share withholding for taxes, and award vesting
Rhea-AI Filing Summary
Robert Chatwani, an officer of DocuSign, reported multiple equity transactions on 09/15/2025. The filing shows a sale of 1,682 shares at $80.30 executed pursuant to a Rule 10b5-1 plan and disposition of 16,020 shares withheld by the issuer to satisfy tax obligations upon RSU/PSU vesting. The report also records a non-priced acquisition of 31,538 shares and numerous restricted stock units and performance stock units granted or settled, increasing holdings across several award series. Post-transactions, beneficial ownership figures are shown for each line (for example, 100,999 shares following one reported acquisition). The Form 4 discloses vesting schedules and performance criteria for PSUs and RSUs but does not provide company results or broader financial guidance.
Positive
- Acquisition of 31,538 shares reported, increasing beneficial ownership to 100,999 shares on that line
- Grant/settlement of multiple RSU and PSU tranches with documented vesting schedules and performance metrics, aligning compensation with company performance
Negative
- Sale of 1,682 shares at $80.30 reported under a Rule 10b5-1 plan
- 16,020 shares withheld by the issuer to satisfy tax obligations upon vesting, reducing net realized share count
Insights
TL;DR: Routine insider activity with mixed buy/sell and equity compensation vesting; not clearly material to valuation alone.
The filing documents a modest sale of 1,682 shares at $80.30 under a Rule 10b5-1 plan and the withholding of 16,020 shares to satisfy taxes on vesting awards. Offsetting those dispositions is a reported acquisition of 31,538 shares (listed as "M" with $0 price) and the settling/granting of multiple RSU and PSU tranches totaling tens of thousands of underlying shares across different vesting schedules and performance conditions. These disclosures primarily reflect compensation mechanics and planned trading rather than a new material development for DOCU's operations or capital structure.
TL;DR: Governance processes appear followed: 10b5-1 sale noted and awards include customary vesting and performance conditions.
The report explicitly states the sale was effected under a Rule 10b5-1 plan, which indicates pre-arranged trading. The RSU and PSU descriptions include clear vesting schedules, acceleration on certain termination/change-in-control events, and performance metrics tied to subscription revenue and free cash flow for FY24 and FY25. The form is signed by an attorney-in-fact, consistent with typical insider filing procedures. No regulatory or compliance issues are disclosed in this Form 4.